2023

1. Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

   New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347

2. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group

   The Lancet. Oncology, Vol. 24, Núm. 7, pp. e293-e311

3. Report of consensus panel 1 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients

   Seminars in Hematology

4. Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients

   Seminars in Hematology